Crossmark

Clinical and economic impact of generic versus brand name meropenem use in an intensive care unit in Colombia

Published Print: 2019-07

Authors

Ordóñez, Karen http://orcid.org/0000-0002-3879-3291
Feinstein, Max M. http://orcid.org/0000-0003-4436-1679
Reyes, Sergio http://orcid.org/0000-0002-7126-376X
Hernández-Gómez, Cristhian http://orcid.org/0000-0002-7633-6155
Pallares, Christian http://orcid.org/0000-0002-6093-7845
Villegas, María V. http://orcid.org/0000-0003-1898-9067
Funding

Funding for this research was provided by:

International Center for Medical Training and Research
License Information

Text and Data Mining valid from 2019-07-01

Version of Record valid from 2019-07-10
More Information

This article is maintained by: Elsevier

Article Title: Clinical and economic impact of generic versus brand name meropenem use in an intensive care unit in Colombia

Journal Title: The Brazilian Journal of Infectious Diseases

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.bjid.2019.06.010

Content Type: article

Copyright: © 2019 Sociedade Brasileira de Infectologia. Published by Elsevier España, S.L.U.

Document is current